NIH-funded research U01 cooperative agreement

TET enzymes and mobile DNA activity in aging

Official title: Dysregulation of TET dioxygenase function as a source of aberrant transposable element expression during human aging

Funded at La Jolla Institute for Immunology · NIH-11301863 · Data updated 2026-11-12

Seeing whether loss of TET enzyme function lets mobile DNA elements become active and trigger inflammation in older adults.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionLa Jolla Institute for Immunology
NIH-funded
Lab location1 site (La Jolla, United States)
Project startMarch 20, 2024
Project endFebruary 28, 2029
Funding year2026
Award (this year)$658,800
NIH project number5U01AI180152-03
Project IDNIH-11301863 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be older adults (for example age 65 and older) or people willing to donate blood or tissue samples for studies of aging-related DNA changes.

Less likely to help

People without age-related inflammation or those unable or unwilling to provide samples are unlikely to receive direct benefit from participation.

What this research studies

Researchers are looking at how TET proteins, which help control DNA methylation, may fail with age and allow normally silent transposable elements (mobile DNA) to turn on. They will examine cells from older people and laboratory models to measure DNA methylation, transposable element expression, DNA damage, and inflammatory signals. The team will use molecular techniques like sequencing and epigenetic mapping and manipulate TET activity in cells to trace cause-and-effect. The goal is to connect specific molecular changes to inflammation seen in aging.

Why it matters

Potential benefit: If successful, this work could point to molecular targets to reduce age-related inflammation and DNA damage, which might help prevent or lessen some aging-related health problems.

How similar studies have gone: Prior work in mice and cultured human cells has shown transposable elements can activate with age and promote inflammation, but applying this specifically to human TET enzyme dysfunction is relatively new.

Where this research is happening

  • La Jolla Institute for Immunology
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Rao, Anjana — La Jolla Institute for Immunology
  • Study coordinator: Rao, Anjana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.